Myxomatous mitral valve disease in dogs - an update and perspectives
Aleksandra Domanjko Petrič
*
Abstract
Myxomatous mitral valve disease is a common cause of congestive heart failure in geriatric dogs. Many studies have been done in terms of epidemiology, pathology, associated neurohormonal changes in the disease progression, prognostic factors, and survival and treatment modalities. The presented paper presents a review of some of the studies in the mitral valve disease story.
Keywords: mitral valve disease, review, dog
References
2. Buchanan J. W, Fox P, Sisson D, Moise S, Prevalence of cardiovascular disorders:Prevalence of cardiovascular diseasesTextbook of Canine and Feline Cardiology 1999; 2nd ed. Philadelphia: WB Saunders; 457-470.
4. Domanjko Petrič A, Hozjan E, Blejec A, Predisposition and survival of different breeds with chronic valvular diseaseProceedings of 17th European College Veterinary Internal Medicine – Companion Animals Congress. 13th-15th September, Budapest, Hungary 2007; 239-
5. Borgarelli M, Savarino P, Crosara S, Santilli R.A, Chiavegato D, Poggi M, Bellino C, La Rosa G, Zanatta R, Haggstrom J, Tarducci A, Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve diseaseJ. Vet. Intern. Med 2008; 22: 120-128. http://dx.doi.org/10.1111/j.1939-1676.2007.0008.
6. Garncarz M, Parzeniecka-Jaworska M, Jank M, Łój M, A retrospective study of clinical signs and epidemiology of chronic valve disease in a group of 207 Dachshunds in PolandActa Vet. Scand 2013; Jul11: 55-52.
7. Pedersen H.D, Lorentzen K.A, Kristensen B.Ø, Echocardiographic mitral valve prolapse in Cavalier King Charles Spaniels:epidemiology and prognostic significance for regurgitationVet. Rec 1999; 144: 315-320. http://dx.doi.org/10.1136/vr.144.12.315.
8. Serfass P, Chetboul V, Sampedrano C.C, Nicolle A, Benalloul T, Laforge H, Gau C, Hébert C, Pouchelon J.L, Tissier R, Retrospective study of 942 small-sized dogs:Prevalence of left apical systolic heart murmur and left-sided heart failure, critical effects of breed and sexJ. Vet. Cardiol 2006; 8: 111-18. http://dx.doi.org/10.1016/j.jvc.2005.10.001.
10. Ohad D.G, Lenchner I, Bdolah-Abram T, Segev G, A loud right-apical systolic murmur is associated with the diagnosis of secondary pulmonary arterial hypertension:Retrospective analysis of data from 201 consecutive client-owned dogs (2006–2007)Vet. J 2013; 198: 690-695. http://dx.doi.org/10.1016/j.tvjl.2013.09.067.
11. Pedersen H.D, Mitral valve prolapse in the dog. Pathogenesis, pathophysiology and comparative aspects or early myxomatous mitral valve disease 2000; Copenhagen: PhD thesis;
12. Ljungvall I, Höglund K, Lilliehöök I, Oyama M.A, Tidholm A, Tvedten H, Hägström J, Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogsJ. Vet. Intern. Med 2013; 27: 1105-1112. http://dx.doi.org/10.1111/jvim.12137.
13. Detweiler DK, Patterson DF, The prevalence and types of cardiovascular disease in dogsAnn N Y Acad Sci 1965; Sep8: 127(1)481-516.
14. Swenson L, Hägström J, Kvart C, Juneja R.K, Relationship between parental cardiac status in Cavalier King Charles Spaniels and prevalence and severity of chronic valvular disease in offspringJ. Amer. Vet. Med. Assoc 1996; 208: 2009-2012.
15. Domanjko Petrič A, Blagus R, Mlakar N, Survival characteristics in the myxomatous mitral valve diseaseProceedings of the 23rd European College Veterinary Internal Medicine – Companion Animals Congress, September 12-15th Liverpool 2013;
16. Häggström J, Boswood A, O’Grady M, Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease:the QUEST studyJ Vet. Intern. Med 2008; 22: 51124-1135. http://dx.doi.org/10.1111/j.1939-1676.2008.0150.x.
17. Häggström J, Boswood A, O’Grady M, Jöns O, Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril:the QUEST studyJ Vet. Intern. Med 2013; Nov-Dec27: 61441-1451.
18. Rasmussen C.E, Falk T, Domanjko Petrič A, Holter monitoring of small breed dogs with advanced myxomatous mitral valve disease with and without a history of syncopeJ. Vet. Intern. Med 2014; 28: 2363-370. http://dx.doi.org/10.1111/jvim.12290.
19. Dillon R, Dell’Italia L. J, Tillson M, Killingsworth C, Denney T, Hathcock J, Botzman L, Left ventricular remodeling in preclinical experimental mitral regurgitation of dogsJ Vet. Cardiol 2012; 14: 173-92. http://dx.doi.org/10.1016/j.jvc.2012.01.012.
22. Reynolds C.A, Brown D.C, Rush J.E, Fox P.R, Nguyenba T.P, Lehmkuhl L.B, Gordon S.G, Kellihan H.B, Stepien R.L, Lefbom B.K, Meier C.K, Oyama M.A, Prediction of first onset of congestive heart failure in dogs with degenerative mitral valve disease:The PREDICT cohort studyJ. Vet. Cardiol 2012; 14: 1193-202. http://dx.doi.org/10.1016/j.jvc.2012.01.008.
24. Bonagura JD, Schober KE, Can ventricular function be assessed by echocardiography in chronic canine mitral valve disease?J Small Anim Pract 2009; Sep50: Suppl 112-24.
25. Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Haggstrom J, Hamlin R, Keene B, Luis-Fuentes V, Stepien R, Guidelines for the diagnosis and treatment of canine chronic valvular heart diseaseJ Vet. Intern. Med 2009; 23: 61142-50. http://dx.doi.org/10.1111/j.1939-1676.2009.0392.x.
27. Kvart C, Häggström J, Pedersen HD, Hansson K, Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitationJ Vet Intern Med 2002; Jan-Feb16: 180-88.
28. Atkins C, Keene B, Brown W, Coats J, Crawford M, Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiencyJ. Am. Vet. Med. Assoc 2007; 23: 1061-1069. http://dx.doi.org/10.2460/javma.231.7.1061.
29. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractionsNew Eng. J. Med 1992; 327: 725-727.
30. Tarnow I, Olsen L.H, Kvart C, Höglund K, Moesgaard S.G, Kamstrup T.S, Pedersen H.D, Häggström J, Predictive value of natriuretic peptides in dogs with mitral valve diseaseVet. J 2009; 180: 195-201. http://dx.doi.org/10.1016/j.tvjl.2007.12.026.
31. Ljungvall I, Höglund K, Carnabuci C, Tidholm A, Häggström J, Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve diseaseJ. Vet. Intern. Med 2011; 25: 1036-1043. http://dx.doi.org/10.1111/j.1939-1676.2011.0774.x.
32. Atkins J, Bonagura S, Ettinger P, Fox S, Gordon J, Häggström R, Hamlin B, Keene (Chair) V, Luis-Fuentes Stepien R, Guidelines for the diagnosis and treatment of canine chronic valvular heart diseaseJ. Vet. Intern. Med 2009; 23: 1142-1150. http://dx.doi.org/10.1111/j.1939-1676.2009.0392.x.
33. Hezzell M.J, Boswood A, Chang Y.M, Moonarmart W, Souttar K, Elliott J, The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve diseaseJ Vet Intern Med 2012; Mar-Apr26: 2302-311.
34. Kanemoto D, Taguchi S, Yokoyama M, Mizuno H, Suzuki T, Kanamoto Open heart surgery with deep hypothermia and cardiopulmonary bypass in small and toy dogsVet. Surg 2010; 39: 674-679.
Copyright
© 2015 Domanjko Petrič A. This is an open-access article published under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of Interest Statement
The authors declared that they have no potential conflict of interest with respect to the authorship and/or publication of this article.
Citation Information
Macedonian Veterinary Review. Volume 38, Issue 1, Pages 13-20, p-ISSN 1409-7621, e-ISSN 1857-7415, DOI: 10.14432/j.macvetrev.2014.11.026, 2015
10.14432/j.macvetrev.2014.11.026
